Nikko Asset Management Americas’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-627,910
Closed -$5.4M 222
2021
Q4
$5.4M Sell
627,910
-68,485
-10% -$673K 0.03% 133
2021
Q3
$8.74M Sell
696,395
-90,488
-11% -$1.25M 0.04% 124
2021
Q2
$12M Sell
786,883
-103,628
-12% -$1.74M 0.05% 120
2021
Q1
$18M Buy
890,511
+116,723
+15% +$2.89M 0.09% 110
2020
Q4
$20.9M Buy
773,788
+101,167
+15% +$2.27M 0.12% 101
2020
Q3
$12.7M Sell
672,621
-55,661
-8% -$988K 0.11% 100
2020
Q2
$12.7M Sell
728,282
-562,791
-44% -$8.57M 0.17% 78
2020
Q1
$11.9M Buy
1,291,073
+11,926
+0.9% +$178K 0.22% 75
2019
Q4
$21.9M Sell
1,279,147
-35,148
-3% -$469K 0.34% 67
2019
Q3
$13.7M Buy
1,314,295
+89,961
+7% +$1.21M 0.24% 80
2019
Q2
$19.1M Buy
1,224,334
+401,888
+49% +$7.18M 0.37% 62
2019
Q1
$15.1M Buy
+822,446
New +$14.6M 0.4% 54

Other funds holding CLLS

Nikko Asset Management Americas's CLLS Position: Q1 2022 in Review

Nikko Asset Management Americas sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 627,910 shares — an estimated $5.4M sold.

Nikko Asset Management Americas first reported a position in CLLS in Q1 2019 and held it in 12 quarters. The position peaked at $21.9M in Q4 2019. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.

  • Nikko Asset Management Americas reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
  • Nikko Asset Management Americas sold 627,910 Cellectis shares in Q1 2022, an estimated $5.4M.
  • Nikko Asset Management Americas first reported a position in Cellectis in Q1 2019 and held it in 12 quarters.
  • Nikko Asset Management Americas's Cellectis position peaked at $21.9M in Q4 2019.
  • 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.

Based on Nikko Asset Management Americas's 13F filing for Q1 2022, filed 6 May 2022.